论文部分内容阅读
目的比较应用微量注射泵与持续皮下泵输注胰岛素治疗高血糖患者的临床疗效和费用,为临床医生选择合适的降糖方案提供依据。方法选择住院高血糖患者,随机分为持续皮下泵胰岛素注射组(皮下泵组)和微量注射泵胰岛素注射组(静脉泵组)各120例,给予一定剂量的胰岛素治疗4h,观察两组降糖效果、胰岛素剂量、低血糖事件及费用情况。结果两组血糖下降差值及低血糖事件差异无统计学意义;静脉泵组所需的胰岛素量较少、费用较低,两组差异有统计学意义(P<0.05)。结论应用微量静脉泵输注胰岛素能够在一定时间内解除高血糖毒性,所需费用较低,低血糖事件也无明显增加,患者在住院期应用微量静脉泵注射胰岛素解除高血糖毒性是可以选择的方法之一。
Objective To compare the clinical curative effect and cost of treating patients with hyperglycemia by using microinjection pump and continuous subcutaneous pump infusion of insulin so as to provide the basis for clinicians to choose suitable hypoglycemic regimen. Methods Inpatients with hyperglycemia were randomly divided into continuous subcutaneous pump insulin injection group (subcutaneous pump group) and microinjection pump insulin injection group (intravenous pump group) of 120 cases, given a dose of insulin for 4 hours, the two groups were observed hypoglycemic Effect, insulin dose, hypoglycemic event, and cost. Results There was no significant difference between the two groups in the difference of blood glucose and the incidence of hypoglycaemia. The required amount of insulin was lower and the cost was lower in the venous pump group. There was significant difference between the two groups (P <0.05). Conclusion The application of intravenous infusion of micro-venous pump in a certain period of time to relieve hyperglycemic toxicity, lower costs, no significant increase in the incidence of hypoglycaemia, patients with intravenous micro-intravenous infusion of insulin in the hospitalization period to relieve hyperglycemia toxicity is optional One of the ways.